Determination of the catechol-O-methyltransferase inhibitor tolcapone and three of its metabolites in animal and human plasma and urine by reversed-phase high-performance liquid chromatography with ultraviolet detection
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-07-09
著者
-
Heizmann P.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
SCHMITT M.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
LEUBE J.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
MARTIN H.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
SANER A.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
Schmitt M.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Saner A.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Martin H.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Leube J.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
関連論文
- Determination of the catechol-O-methyltransferase inhibitor tolcapone and three of its metabolites in animal and human plasma and urine by reversed-phase high-performance liquid chromatography with ultraviolet detection
- Determination of the renin inhibitor Ro 42-5892 in human plasma by automated pre-column derivatization, reversed-phase high-performance liquid chromatographic separation and electrochemical detection after post-column irradiation